Delivery Order SPE2DB22D3004-SPE2DB25FRU96
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $6,492.02 delivery order to AmerisourceBergen Drug Corp for FORTEO (forteoide) 560 mcg/2.24 mL pen injections on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order to be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. FORTEO is a prescription injectable medication commonly used in the treatment of osteoporosis...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of FORTEO (fortified with 560 mcg/2.24 mL pen injections). The contract, which became effective on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Conshohocken facility....
- The Defense Logistics Agency awarded a delivery order valued at $47,923.50 to AmerisourceBergen Drug Corp for the supply of FORTEO (560 mcg/2.24 mL pen injection), a pharmaceutical treatment for osteoporosis. The contract, awarded on April 21, 2025, with an ultimate completion date of April 22, 2025, was issued without a set-aside designation under a firm fixed price arrangement. Performance of this delivery order will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $19,378.19 delivery order to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections on August 20, 2025, with completion scheduled for August 21, 2025. This competitive award, which utilized no set-aside designation, was issued under a firm fixed-price contract structure and represents a single delivery order for pharmaceutical supplies to be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. FORTEO is a bone-building...
- The Defense Logistics Agency awarded a $14,640.18 delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injections) on April 24, 2025, with completion scheduled for April 25, 2025. This competitive award utilizes firm fixed pricing and is performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,220.43 for FORTEO 560 mcg/2.24 mL pen injections on June 3, 2025, with completion targeted for June 4, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio. The product will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FORTEO (Fortified Growth Factor) 560 MCG/2.24 ML pen injections on June 18, 2025, with completion targeted for June 20, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement to support federal medical supply needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $11,404.44 to AmerisourceBergen Drug Corp for the supply of FORTEO 560 MCG/2.24 ML pen injections on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $12,869.67 delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injections), a brand-name pharmaceutical product used in osteoporosis treatment. The contract is a firm fixed-price delivery order with an ultimate completion date of May 19, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRU96Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,513.76 to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. FORTEO is a prescription medication commonly used to treat osteoporosis and bone-related conditions in military and veteran populations served by the Defense Health Agency. This delivery order is executed under AmerisourceBergen's $999.999 billion IDC with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen maintains an extensive portfolio of federal contracts involving brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its established capability to meet federal procurement requirements and support critical medical supply chains for the Department of Defense and related healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/4/25 |